valine has been researched along with Obesity in 65 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (23.08) | 18.7374 |
1990's | 3 (4.62) | 18.2507 |
2000's | 16 (24.62) | 29.6817 |
2010's | 20 (30.77) | 24.3611 |
2020's | 11 (16.92) | 2.80 |
Authors | Studies |
---|---|
Bulló, M; Halford, JCG; Hansen, TT; Harrold, JA; Papandreou, C; Sjödin, A | 1 |
Bishop, CA; Grune, T; Henkel, J; Henning, T; Klaus, S; Machate, T; Püschel, G; Weber, D; Weitkunat, K | 1 |
Caspers, MPM; Gart, E; Keijer, J; Kleemann, R; Menke, A; Morrison, MC; Salic, K; Snabel, J; van Duyvenvoorde, W; van Trigt, N | 1 |
Chen, S; Eguchi, M; Fukunaga, A; Kabe, I; Kochi, T; Miki, T; Mizoue, T; Nanri, A | 1 |
Lenart-Lipinska, M; Matyjaszek-Matuszek, B; Szmygin, H; Szydelko, J; Wozniak, S | 1 |
Bloks, VW; C L van den Munckhof, I; Chen, L; Doestzada, M; Fu, J; Joosten, LAB; Kuipers, F; Kurilshikov, A; Netea, MG; Riksen, NP; Rutten, JHW; van Faassen, M; Wang, D; Wijmenga, C; Zhernakova, A; Zhernakova, DV | 1 |
Alvarez, M; André Drevon, C; Birkeland, KI; Bjune, MS; Claussnitzer, M; Dankel, SN; Heinonen, S; Jersin, RÅ; Lee-Ødegård, S; McCann, A; Mellgren, G; Muniandy, M; Pajukanta, P; Pietiläinen, KH; Skartveit, L; Sri Priyanka Tallapragada, D | 1 |
Atwal, PS; Bersten, DC; Blackburn, PR; Caulfield, TR; Cooiman, M; Gerassimou, AG; Harris, KG; Klee, EW; Kleinendorst, L; Ross, OA; Sullivan, AE; van Gerpen, JA; van Haelst, MM; Whitelaw, ML; Wierenga, KJ | 1 |
Brozinick, JT; Carson, MW; Christopher, BA; Crown, SB; Foster, MW; Gersbach, CA; Gimeno, RE; Hammond, CD; Ilkayeva, O; Kajimura, S; McGarrah, RW; Moseley, MA; Muehlbauer, MJ; Newgard, CB; Page, S; Pickar-Oliver, A; van Vliet, S; Walejko, JM; White, PJ; Yoneshiro, T; Zhang, GF | 1 |
Hu, X; Jin, H; Li, J; Shao, D; Shi, J; Yan, X | 1 |
Alexander, CM; Baur, JA; Brinkman, JA; Cheng, EP; Finke, M; Flores, V; Green, CL; Haider, LR; Jang, C; Kasza, I; Konon, EN; Lamming, DW; Malecki, KC; Miller, BR; Murphy, ME; Nikodemova, M; Pak, HH; Quinn, WJ; Rabinowitz, JD; Richardson, NE; Rojas, JM; Sonsalla, M; Spicer, AB; Tomasiewicz, JL; Wakai, MH; Yang, SE; Yu, D | 1 |
Cho, S; Park, KW; Yang, J | 1 |
Assadi-Porter, FM; Butz, DE; Chiellini, G; Haviland, JA; Porter, WP; Reiland, H; Scanlan, TS; Tonelli, M; Zucchi, R | 1 |
Hasan, AU; Hashimoto, T; Ishihara, N; Ishihara, Y; Kamitori, K; Kohno, M; Noma, T; Ohmori, K; Tokuda, M; Yamaguchi, F | 1 |
Ahn, JH; Cha, BS; Choi, CS; Kang, ES; Kim, YW; Lee, BW; Lee, EY; Lee, HC; Oh, H | 1 |
Corradi, L; Derosa, G; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Santoro, T; Zoppi, A | 1 |
Djan, I; Djan, M; Plećas, A; Srdić, B; Stokić, E; Vapa, Lj | 1 |
Bassols, J; Botas, P; Delgado, E; Fernández-Real, JM; Menéndez, JA; Moreno-Navarrete, JM; Ortega, FJ; Pardo, G; Ricart, W; Valdés, S; Vázquez-Martín, A | 1 |
Cheng, M; Lindpaintner, K; Liu, L; Liu, X; Ma, L; Ma, X; Peng, Z; Ruan, X; Wang, B; Wang, S; Wang, X; Zhang, J | 1 |
Brown, RE; Imran, SA; Wilkinson, M | 1 |
Deedwania, PC; Egan, BM; Jialal, I; Ofili, EO; Purkayastha, D; Raij, L; Samuel, R; Sowers, JR; Zappe, DH | 1 |
Rudolph, A; Weintraub, HS | 1 |
Akhtari, S; Andalib, A; Curnew, G; Leclerc, JM; Rigal, R; Tardif, JC; Vaillancourt, M | 1 |
Circelli, M; Cremonesi, G; Fogari, R; Mugellini, A | 1 |
Matsuura, K; Mori, Y; Tanaka, T; Utsunomiya, K; Yokoyama, J | 1 |
Borovecki, F; Curkovic, M; Dodig-Curkovic, K; Nikolac, M; Pivac, N; Skledar, M | 1 |
Dralova, OV; Ermolaeva, AS; Maksimov, ML | 1 |
Egan, BM; Purkayastha, D; Raij, L; Samuel, R; Sowers, JR; Zappe, DH | 1 |
Han, G; Lieberman, K; Meyers, KE; Shi, V; Solar-Yohay, S | 1 |
Biskupiak, J; Qian, C; Quah, R; Ram, CV; Ramaswamy, K; Russo, PA; Ryan, A | 1 |
Clish, CB; Deik, AA; Fleischman, A; Gerszten, RE; Grinspoon, SK; McCarthy, MA; McCormack, SE; Mootha, VK; Shaham, O; Wang, TJ | 1 |
Brozinick, JT; Grove, K; Hawkins, E; Hoang Bui, H; Kievit, P; Kuo, MS; Tan, B | 1 |
Goto, SN; Mizuno, Y; Takagi, H; Umemoto, T; Yamamoto, H | 1 |
Björntorp, P; Bouchard, C; Rosmond, R | 1 |
Baier, LJ; Bogardus, C; Hanson, RL; Harper, I; Infante, AM; Kovacs, P; Tataranni, PA | 1 |
Heist, K; Kontogianni, M; Mantzoros, CS; Melistas, L; Yiannakouris, N | 1 |
Ambrosi, P; Andrejak, M; Drici, MD; Herpin, D; Pithois-Merli, I | 1 |
Bönner, G; Heintz, D; Kandra, A; Khder, Y; Malacco, E; Ruilope, LM | 1 |
Derosa, G; Fogari, E; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Rinaldi, A; Zoppi, A | 1 |
Boschmann, M; Engeli, S; Jordan, J; Kreuzberg, U; Luft, FC; Sharma, AM; Weidinger, G | 1 |
Hirata, Y; Hirono, Y; Sugiyama, T; Tateno, T; Tsuchiya, K; Yoshimoto, T | 1 |
Adams, F; Boschmann, M; Engeli, S; Franke, G; Jordan, J; Klaua, S; Kreuzberg, U; Luft, FC; Scholze, J; Sharma, AM; Weidinger, G | 1 |
Itoh, Y; Mori, Y; Tajima, N | 1 |
Davidson, J; Koval, S; Lacourcière, Y; Sharma, AM | 1 |
Horiuchi, M; Inaba, S; Iwai, M; Mogi, M; Tomono, Y | 1 |
Boehm, TM; Bongiovanni, R; Glass, AR; Smith, CE | 1 |
Groop, L; Klannemark, M; Orho, M | 1 |
Albu, J; Allison, DB; Burn, P; Chin, W; Deng, N; Duprat, L; Fisher, SL; Franco, LS; Gu, W; Heymsfield, S; Kissebah, A; Kleyn, PW; Lee, J; Maruti, S; Nathan, J; Pi-Sunyer, FX; Tu, Z; Yagaloff, KA | 1 |
Palou, A; Proenza, AM; Roca, P | 1 |
Astrup, A; Bibby, BM; Buemann, B; Dalgaard, L; Pedersen, O; Schierning, B; Sørensen, T; Toubro, S | 1 |
Dunseath, G; Luzio, SD; Owens, DR | 1 |
Chaussain, JL; Georges, P; Job, JC; Olive, G | 1 |
Herbertz, L; Langer, K; Schauder, P; Zavelberg, D | 1 |
Fletcher, JM; Haggarty, P; Reeds, PJ; Wahle, KW | 1 |
Owen, OE; Pozefsky, T; Sapir, DG; Walser, M | 1 |
Briel, G; Gylfe, E; Hellman, B; Neuhoff, V | 1 |
Gylfe, E | 1 |
Genuth, SM | 1 |
Hellerström, C; Schmidt, FH; Stork, H; Westman, S | 1 |
Adibi, SA; Drash, AL | 1 |
Adibi, SA | 1 |
Bourges, HR; Farrish, GC; Gray, SJ; Ross, JR; Steiner, M | 1 |
Farrish, GC; Gray, SJ; Steiner, M | 1 |
Cahill, GF; Felig, P; Marliss, E | 1 |
Drenick, EJ; Figueroa, WS; Swendseid, ME; Villalobos, J | 1 |
6 review(s) available for valine and Obesity
Article | Year |
---|---|
Branched-chain amino acids as a novel biomarker of metabolic disturbances in women with polycystic ovary syndrome - literature review.
Topics: Amino Acids, Branched-Chain; Animals; Biomarkers; Diabetes Mellitus, Type 2; Female; Humans; Insulin Resistance; Isoleucine; Leucine; Obesity; Polycystic Ovary Syndrome; Prediabetic State; Valine | 2022 |
Combination therapy for managing difficult-to-treat patients with stage 2 hypertension: focus on valsartan-based combinations.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Black or African American; Calcium Channel Blockers; Diuretics; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Obesity; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2011 |
Combination delapril/manidipine as antihypertensive therapy in high-risk patients.
Topics: Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Clinical Trials as Topic; Diabetes Complications; Dihydropyridines; Drug Combinations; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Indans; Irbesartan; Losartan; Nitrobenzenes; Obesity; Olmesartan Medoxomil; Piperazines; Ramipril; Tetrazoles; Valine; Valsartan | 2011 |
[Hypertension, obesity, erectile dysfunction. What kind of drug to choose].
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Erectile Dysfunction; Humans; Hypertension; Male; Obesity; Renin-Angiotensin System; Risk Factors; Tetrazoles; Valine; Valsartan | 2011 |
Effects of telmisartan therapy on interleukin-6 and tumor necrosis factor-alpha levels: a meta-analysis of randomized controlled trials.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Confidence Intervals; Cross-Over Studies; Double-Blind Method; Humans; Hypertension; Hypertension, Renal; Imidazoles; Interleukin-6; Obesity; Prospective Studies; Publication Bias; Randomized Controlled Trials as Topic; Stents; Telmisartan; Tetrazoles; Tumor Necrosis Factor-alpha; Valine; Valsartan | 2013 |
[The best of clinical pharmacology in 2004].
Topics: Angina Pectoris; Angiotensin II Type 1 Receptor Blockers; Cardiovascular Diseases; Diabetes Complications; Humans; Obesity; Tetrazoles; Valine; Valsartan | 2005 |
12 trial(s) available for valine and Obesity
Article | Year |
---|---|
Changes in Circulating Metabolites during Weight Loss and Weight Loss Maintenance in Relation to Cardiometabolic Risk.
Topics: Adult; Aged; Body Mass Index; Body Weight Maintenance; Caloric Restriction; Cardiometabolic Risk Factors; Cholesterol; Cholesterol, LDL; Female; Humans; Linear Models; Male; Middle Aged; Obesity; Phosphatidylcholines; Prospective Studies; Satiation; Sphingomyelins; Triglycerides; Valine; Weight Loss; Young Adult | 2021 |
Effect of valsartan addition to amlodipine on insulin sensitivity in overweight-obese hypertensive patients.
Topics: Adult; Aged; Amlodipine; Cross-Over Studies; Drug Therapy, Combination; Female; Humans; Hypertension; Insulin; Male; Middle Aged; Obesity; Overweight; Prospective Studies; Tetrazoles; Valine; Valsartan | 2008 |
Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Blood Glucose; Blood Pressure; Body Mass Index; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Female; Glucose Tolerance Test; Humans; Hydrochlorothiazide; Hypertension; Insulin; Male; Middle Aged; Obesity; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2010 |
Influence of telmisartan on insulin response after glucose loading in obese patients with hypertension: ARB trial of hypertension in obese patients with hyperinsulinemia assessed by oral glucose tolerance test (ATHLETE).
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Glucose; Blood Pressure; Female; Glucose; Glucose Tolerance Test; Humans; Hyperinsulinism; Hypertension; Insulin Resistance; Male; Obesity; Telmisartan; Tetrazoles; Valine; Valsartan | 2011 |
Office and ambulatory blood pressure-lowering effects of combination valsartan/hydrochlorothiazide vs. hydrochlorothiazide-based therapy in obese, hypertensive patients.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Comorbidity; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Obesity; Office Visits; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2011 |
The efficacy and safety of valsartan in obese and non-obese pediatric hypertensive patients.
Topics: Adolescent; Antihypertensive Agents; Blood Pressure; Child; Comorbidity; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypertension; International Cooperation; Male; Obesity; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2011 |
Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Topics: Age Factors; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Cerebrovascular Disorders; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypercholesterolemia; Hypertension; Male; Middle Aged; Myocardial Infarction; Obesity; Risk Factors; Tetrazoles; Valine; Valsartan | 2005 |
Comparison of the effects of valsartan and felodipine on plasma leptin and insulin sensitivity in hypertensive obese patients.
Topics: Aged; Antihypertensive Agents; Felodipine; Female; Humans; Hypertension; Insulin Resistance; Leptin; Male; Middle Aged; Obesity; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2005 |
Hemodynamic and metabolic responses to valsartan and atenolol in obese hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atenolol; Blood Glucose; Blood Pressure; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Lipids; Male; Middle Aged; Obesity; Sodium Chloride Symporter Inhibitors; Tetrazoles; Valine; Valsartan | 2005 |
The effect of oral glucose loads on tissue metabolism during angiotensin II receptor and beta-receptor blockade in obese hypertensive subjects.
Topics: Adipose Tissue; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Ethanol; Fatty Acids, Nonesterified; Female; Glucose; Glucose Tolerance Test; Glycerol; Humans; Hypertension; Insulin; Kinetics; Lactic Acid; Lipids; Male; Metabolism; Middle Aged; Muscle, Skeletal; Obesity; Tetrazoles; Valine; Valsartan | 2006 |
Telmisartan/hydrochlorothiazide versus valsartan/hydrochlorothiazide in obese hypertensive patients with type 2 diabetes: the SMOOTH study.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Diabetes Mellitus, Type 2; Diastole; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Male; Middle Aged; Obesity; Placebos; Single-Blind Method; Systole; Telmisartan; Tetrazoles; Valine; Valsartan | 2007 |
Acute effects of valsartan on insulin sensitivity in obese, non-hypertensive subjects with and without type 2 diabetes.
Topics: Adolescent; Adult; Antihypertensive Agents; Cross-Over Studies; Diabetes Mellitus; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Obesity; Tetrazoles; Valine; Valsartan | 2002 |
47 other study(ies) available for valine and Obesity
Article | Year |
---|---|
Detrimental effects of branched-chain amino acids in glucose tolerance can be attributed to valine induced glucotoxicity in skeletal muscle.
Topics: Amino Acids, Branched-Chain; Animals; Glucose; Insulin Resistance; Leucine; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Obesity; Valine | 2022 |
Intervention with isoleucine or valine corrects hyperinsulinemia and reduces intrahepatic diacylglycerols, liver steatosis, and inflammation in Ldlr-/-.Leiden mice with manifest obesity-associated NASH.
Topics: Amino Acids, Branched-Chain; Animals; Diglycerides; Hyperinsulinism; Inflammation; Isoleucine; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Valine | 2022 |
Associations of serum amino acids with insulin resistance among people with and without overweight or obesity: A prospective study in Japan.
Topics: Alanine; Animals; Humans; Insulin; Insulin Resistance; Isoleucine; Japan; Methionine; Obesity; Overweight; Prospective Studies; Thinness; Tyrosine; Valine | 2022 |
Systematic analysis of relationships between plasma branched-chain amino acid concentrations and cardiometabolic parameters: an association and Mendelian randomization study.
Topics: Amino Acids, Branched-Chain; Atherosclerosis; Cross-Sectional Studies; Diabetes Mellitus; Humans; Isoleucine; Mendelian Randomization Analysis; Obesity; Valine | 2022 |
Impaired Adipocyte SLC7A10 Promotes Lipid Storage in Association With Insulin Resistance and Altered BCAA Metabolism.
Topics: Adipocytes; Amino Acids; Amino Acids, Branched-Chain; Animals; Fatty Acids; Glucose; Humans; Insulin Resistance; Lipid Metabolism; Mice; Obesity; RNA, Messenger; Tandem Mass Spectrometry; Valine | 2023 |
Functional Analysis of the SIM1 Variant p.G715V in 2 Patients With Obesity.
Topics: Adult; Amino Acid Substitution; Basic Helix-Loop-Helix Transcription Factors; Genetic Association Studies; Glutamic Acid; Humans; Male; Middle Aged; Mutation, Missense; Obesity; Prader-Willi Syndrome; Repressor Proteins; Valine | 2020 |
Branched-chain α-ketoacids are preferentially reaminated and activate protein synthesis in the heart.
Topics: Amino Acids, Branched-Chain; Animals; Heart; Hemiterpenes; Keto Acids; Male; Mice; Mice, Inbred C57BL; Mitochondria; Obesity; Rats; Valine | 2021 |
The anti-obesity effects exerted by different fractions of Artemisia sphaerocephala Krasch polysaccharide in diet-induced obese mice.
Topics: Animals; Anti-Obesity Agents; Artemisia; Diet, High-Fat; Gastrointestinal Microbiome; Isoleucine; Leucine; Liver; Male; Mice; Mice, Inbred C57BL; Nitrogen; Obesity; Plant Extracts; Polysaccharides; Valine | 2021 |
The adverse metabolic effects of branched-chain amino acids are mediated by isoleucine and valine.
Topics: Adipose Tissue, White; Amino Acids, Branched-Chain; Animals; Body Mass Index; Diet; Energy Metabolism; Fibroblast Growth Factors; Humans; Isoleucine; Liver; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Inbred C57BL; Mice, Knockout; Obesity; Protein Serine-Threonine Kinases; Uncoupling Protein 1; Valine | 2021 |
Inhibition of the CD36 receptor reduces visceral fat accumulation and improves insulin resistance in obese mice carrying the BDNF-
Topics: Animals; Benzofurans; Brain-Derived Neurotrophic Factor; CD36 Antigens; Cell Differentiation; Diet, High-Fat; Insulin Resistance; Intra-Abdominal Fat; Male; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Mutation; Obesity; Valine | 2018 |
NMR-based metabolomics and breath studies show lipid and protein catabolism during low dose chronic T(1)AM treatment.
Topics: 3-Hydroxybutyric Acid; Animals; Body Weight; Breath Tests; Dietary Proteins; Dose-Response Relationship, Drug; Female; Glycine; Lipolysis; Magnetic Resonance Spectroscopy; Metabolomics; Mice; Obesity; Thyronines; Valine; Weight Loss | 2013 |
Valsartan ameliorates the constitutive adipokine expression pattern in mature adipocytes: a role for inverse agonism of the angiotensin II type 1 receptor in obesity.
Topics: 3T3-L1 Cells; Active Transport, Cell Nucleus; Adipocytes; Adipokines; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Chlorocebus aethiops; COS Cells; Drug Inverse Agonism; Interleukin-6; Mice; NF-kappa B; Obesity; PPAR gamma; Receptor, Angiotensin, Type 1; Tetrazoles; Valine; Valsartan | 2014 |
Anti-obesity effects of KR-66195, a synthetic DPP-IV inhibitor, in diet-induced obese mice and obese-diabetic ob/ob mice.
Topics: Animals; Anti-Obesity Agents; Blood Glucose; Body Composition; Diabetes Mellitus; Diet, High-Fat; Dipeptidyl Peptidase 4; Eating; Energy Metabolism; Enzyme Inhibitors; Female; Glucagon-Like Peptide 1; Glucose Tolerance Test; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Random Allocation; Thiazolidines; Treatment Outcome; Valine; Weight Gain | 2014 |
Polymorphism Val103Ile of the melanocortin-4 receptor gene in the Serbian population.
Topics: Adult; Amino Acid Substitution; Female; Heterozygote; Homozygote; Humans; Isoleucine; Male; Obesity; Polymorphism, Single Nucleotide; Receptor, Melanocortin, Type 4; Serbia; Valine | 2010 |
Val1483Ile in FASN gene is linked to central obesity and insulin sensitivity in adult white men.
Topics: Adipose Tissue; Adiposity; Adult; Age Factors; Blood Glucose; Blood Pressure; Body Mass Index; Case-Control Studies; Down-Regulation; Fatty Acid Synthase, Type I; Female; Gene Frequency; Genetic Predisposition to Disease; Humans; Insulin Resistance; Isoleucine; Male; Middle Aged; Obesity; Phenotype; Polymorphism, Single Nucleotide; Risk Factors; Sex Factors; Time Factors; Valine; Waist-Hip Ratio; Weight Gain | 2009 |
TAQIB and I405V polymorphisms of CETP are moderately associated with obesity risk in the Chinese adult population.
Topics: Adult; Amino Acid Substitution; Asian People; Case-Control Studies; Cholesterol Ester Transfer Proteins; Deoxyribonucleases, Type II Site-Specific; Female; Genetic Predisposition to Disease; Genetics, Population; Humans; Isoleucine; Male; Middle Aged; Obesity; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Risk; Valine | 2010 |
Tissue-specific effects of valsartan on rstn and fiaf gene expression in the ob/ob mouse.
Topics: Angiopoietin-Like Protein 4; Angiopoietins; Angiotensin II Type 1 Receptor Blockers; Animals; Cerebral Cortex; Diabetes Mellitus; Disease Models, Animal; Gene Expression Regulation; Hypothalamus; Intra-Abdominal Fat; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Pituitary Gland; Resistin; RNA, Messenger; Subcutaneous Fat; Tetrazoles; Time Factors; Valine; Valsartan | 2010 |
Determinants of masked hypertension in hypertensive patients treated in a primary care setting.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Cardiovascular Diseases; Comorbidity; Diabetes Complications; Drug Therapy, Combination; Dyslipidemias; Female; Heart Failure; Humans; Hydrochlorothiazide; Hypertension; Male; Masked Hypertension; Middle Aged; Obesity; Prevalence; Primary Health Care; Quebec; Risk; Tetrazoles; Valine; Valsartan; White Coat Hypertension | 2012 |
Association between brain-derived neurotrophic factor Val66Met and obesity in children and adolescents.
Topics: Adolescent; Alleles; Amino Acid Substitution; Body Mass Index; Brain-Derived Neurotrophic Factor; Child; Child, Preschool; Croatia; Eating; Energy Metabolism; Female; Genetic Association Studies; Humans; Male; Methionine; Obesity; Polymorphism, Genetic; Valine | 2012 |
Blood pressure outcomes in patients receiving angiotensin II receptor blockers in primary care: a comparative effectiveness analysis from electronic medical record data.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Black or African American; Blood Pressure; Diabetes Mellitus; Electronic Health Records; Female; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Male; Middle Aged; Obesity; Primary Health Care; Retrospective Studies; Tetrazoles; Treatment Outcome; Valine; Valsartan; White People; Young Adult | 2011 |
Circulating branched-chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents.
Topics: Adolescent; Amino Acids, Branched-Chain; Biomarkers; Blood Glucose; Body Mass Index; Child; Child Nutrition Disorders; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Fasting; Female; Humans; Insulin; Insulin Resistance; Insulin Secretion; Isoleucine; Leucine; Longitudinal Studies; Male; Massachusetts; Obesity; Predictive Value of Tests; Valine | 2013 |
Plasma sphingolipids are biomarkers of metabolic syndrome in non-human primates maintained on a Western-style diet.
Topics: Animals; Biomarkers; Ceramides; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Disease Progression; Fructose; Insulin Resistance; Macaca mulatta; Male; Metabolic Syndrome; Obesity; Risk Factors; Serine C-Palmitoyltransferase; Sphingolipids; Valine | 2013 |
Lack of association between the uncoupling protein-2 Ala55Val gene polymorphism and phenotypic features of the Metabolic Syndrome.
Topics: Alanine; Alleles; Blood Glucose; Blood Pressure; Humans; Insulin; Ion Channels; Male; Membrane Transport Proteins; Metabolic Syndrome; Middle Aged; Mitochondrial Proteins; Obesity; Phenotype; Proteins; Sweden; Uncoupling Protein 2; Valine | 2002 |
A novel missense substitution (Val1483Ile) in the fatty acid synthase gene (FAS) is associated with percentage of body fat and substrate oxidation rates in nondiabetic Pima Indians.
Topics: Adipose Tissue; Adult; Alleles; Carbohydrate Metabolism; Fatty Acid Synthases; Gene Frequency; Genetic Variation; Humans; Indians, North American; Isoleucine; Mutation, Missense; Obesity; Oxidation-Reduction; Valine | 2004 |
The Val81 missense mutation of the melanocortin 3 receptor gene, but not the 1908c/T nucleotide polymorphism in lamin A/C gene, is associated with hyperleptinemia and hyperinsulinemia in obese Greek caucasians.
Topics: Adult; Amino Acid Substitution; Body Composition; Body Mass Index; DNA; Female; Gene Frequency; Greece; Humans; Hyperinsulinism; Insulin; Lamin Type A; Leptin; Male; Mutation, Missense; Obesity; Polymorphism, Genetic; Receptor, Melanocortin, Type 3; Regression Analysis; Valine | 2004 |
Angiotensin II induces monocyte chemoattractant protein-1 expression via a nuclear factor-kappaB-dependent pathway in rat preadipocytes.
Topics: Adipocytes; Adipose Tissue; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Cell Differentiation; Chemokine CCL2; Humans; Male; NF-kappa B; Nitriles; Obesity; Promoter Regions, Genetic; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfones; Tetrazoles; Thiocarbamates; Transcription, Genetic; Valine; Valsartan | 2006 |
Angiotensin II receptor blockers downsize adipocytes in spontaneously type 2 diabetic rats with visceral fat obesity.
Topics: Adipocytes; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Glucose; Calcium Channel Blockers; Cell Size; Diabetes Mellitus, Type 2; Disease Models, Animal; Insulin; Intra-Abdominal Fat; Male; Obesity; PPAR gamma; Random Allocation; Rats; Rats, Long-Evans; Telmisartan; Tetrazoles; Valine; Valsartan | 2007 |
Blockade of AT1 receptor improves adipocyte differentiation in atherosclerotic and diabetic models.
Topics: Adipocytes, White; Adiponectin; Angiotensin II Type 1 Receptor Blockers; Animals; Apolipoproteins E; Atherosclerosis; Cell Differentiation; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Models, Animal; Gene Deletion; Gene Expression; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Obesity; PPAR gamma; Receptor, Angiotensin, Type 1; Tetrazoles; Valine; Valsartan | 2008 |
Normal valine disposal in obese subjects with impaired glucose disposal: evidence for selective insulin resistance.
Topics: Blood Glucose; Female; Glucose; Humans; Insulin; Insulin Resistance; Male; Metabolic Clearance Rate; Obesity; Valine | 1981 |
No relationship between identified variants in the uncoupling protein 2 gene and energy expenditure.
Topics: Aged; Alanine; Amino Acid Substitution; Energy Metabolism; Exons; Female; Genetic Variation; Genotype; Humans; Introns; Ion Channels; Male; Membrane Transport Proteins; Middle Aged; Mitochondrial Proteins; Molecular Sequence Data; Obesity; Polymorphism, Single-Stranded Conformational; Proteins; Syndrome; Uncoupling Protein 2; Valine | 1998 |
Identification and functional analysis of novel human melanocortin-4 receptor variants.
Topics: Adolescent; Adult; Amino Acid Substitution; Animals; Body Mass Index; Cloning, Molecular; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Genetic Predisposition to Disease; Genetic Variation; Genotype; Humans; Isoleucine; Male; Methionine; Mice; Middle Aged; Obesity; Pedigree; Polymorphism, Single-Stranded Conformational; Receptor, Melanocortin, Type 4; Receptors, Peptide; Recombinant Proteins; Threonine; Valine | 1999 |
Sex differences in the effect of obesity on human plasma tryptophan/large neutral amino acid ratio.
Topics: Amino Acids; Body Mass Index; Female; Humans; Leucine; Male; Obesity; Phenylalanine; Sex Characteristics; Tryptophan; Tyrosine; Valine | 1999 |
The association between the val/ala-55 polymorphism of the uncoupling protein 2 gene and exercise efficiency.
Topics: Adult; Alanine; Calorimetry, Indirect; Energy Metabolism; Exercise; Exercise Test; Female; Genotype; Homozygote; Humans; Linkage Disequilibrium; Male; Obesity; Oxygen Consumption; Polymorphism, Genetic; Saccharomyces cerevisiae Proteins; Trans-Activators; Valine | 2001 |
Effect of 24 hour fast in obese children.
Topics: Adolescent; Alanine; Blood Glucose; Child; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Growth Hormone; Humans; Insulin; Isoleucine; Ketone Bodies; Leucine; Male; Obesity; Valine | 1976 |
Sex-specific differences in plasma branched-chain keto acid levels in obesity.
Topics: Blood Glucose; Body Composition; Female; Hemiterpenes; Humans; Insulin; Insulin Resistance; Isoleucine; Keto Acids; Leucine; Male; Middle Aged; Obesity; Sex Characteristics; Valine | 1987 |
The fate of 14C derived from radioactively labelled dietary precursors in young rats of the Zucker strain (Fa/- and fa/fa).
Topics: Animals; Carbon Radioisotopes; Glucose; Lactates; Lactic Acid; Leucine; Obesity; Palmitic Acid; Palmitic Acids; Rats; Rats, Zucker; Valine | 1986 |
Nitrogen sparing induced by a mixture of essential amino acids given chiefly as their keto-analogues during prolonged starvation in obese subjects.
Topics: Amino Acids; Female; Humans; Infusions, Parenteral; Isoleucine; Keto Acids; Leucine; Methionine; Nitrogen; Obesity; Phenylalanine; Starvation; Urea; Valine | 1974 |
Microdetermination of free amino acids in pancreatic islets isolated from obese-hyperglycemic mice.
Topics: Amino Acids; Animals; Binding Sites; Carbon Isotopes; Chromatography, Thin Layer; Dansyl Compounds; Fatty Acids, Nonesterified; Hyperglycemia; Islets of Langerhans; Leucine; Mice; Obesity; Taurine; Valine | 1972 |
Changes of free amino acids in pancreatic beta-cells after starvation and substrate deprivation.
Topics: Alanine; Amino Acids; Aminobutyrates; Animals; Aspartic Acid; Carbon Radioisotopes; Chromatography, Thin Layer; Dansyl Compounds; Diabetes Mellitus; Fasting; Female; Freeze Drying; Glutamates; Glycine; Islets of Langerhans; Leucine; Lysine; Mice; Obesity; Ornithine; Phenylalanine; Proline; Taurine; Tritium; Valine | 1974 |
Effects of oral alanine administration in fasting obese subjects.
Topics: Administration, Oral; Adult; Alanine; Blood Glucose; Female; Gluconeogenesis; Humans; Hydroxybutyrates; Insulin; Isoleucine; Leucine; Male; Middle Aged; Nitrogen; Obesity; Phosphorus; Potassium; Urea; Uric Acid; Valine | 1973 |
[Effect of blood sugar decreasing sulfonylureas on the in vitro metabolism of glucose and amino acids in the beta-cells of the pancreas in mice].
Topics: Alanine; Amino Acids; Animals; Arginine; Carbon Isotopes; Depression, Chemical; Female; Glucose; Hyperglycemia; Hypoglycemic Agents; In Vitro Techniques; Insulin; Islets of Langerhans; Leucine; Male; Mice; Obesity; Oxidation-Reduction; Oxygen Consumption; Pancreas; Stimulation, Chemical; Tolbutamide; Urea; Valine | 1969 |
Hormone and amino acid levels in altered nutritional states.
Topics: Adult; Alanine; Amino Acids; Aminobutyrates; Female; Growth Hormone; Humans; Insulin; Isoleucine; Leucine; Male; Nutritional Physiological Phenomena; Obesity; Protein Deficiency; Starvation; Valine | 1970 |
Alteration in the urinary excretion rate of amino acids and nitrogen by dietary means in obese and normal human subjects.
Topics: Adult; Alanine; Amino Acids; Creatinine; Female; Humans; Isoleucine; Leucine; Male; Nitrogen; Obesity; Protein Deficiency; Renal Aminoacidurias; Starvation; Taurine; Urea; Valine | 1971 |
Intestinal uptake of valine in obesity.
Topics: Adaptation, Psychological; Adult; Biopsy; Carbon Isotopes; DNA; Female; Humans; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Kinetics; Male; Middle Aged; Obesity; Valine | 1969 |
Intestinal uptake of valine in calorie and protein deprivation.
Topics: Adult; Biopsy; Blood Glucose; Blood Urea Nitrogen; Body Weight; Carbon Isotopes; Cholesterol; Creatinine; Fatty Acids; Fatty Acids, Nonesterified; Female; Humans; Intestinal Absorption; Intestinal Mucosa; Jejunum; Male; Middle Aged; Obesity; Protein Deficiency; Starvation; Time Factors; Triglycerides; Uric Acid; Valine | 1969 |
Plasma amino acid levels and insulin secretion in obesity.
Topics: Adolescent; Adult; Amino Acids; Blood Glucose; Fasting; Feedback; Female; Glucose; Glycine; Humans; Insulin; Insulin Resistance; Insulin Secretion; Isoleucine; Leucine; Male; Middle Aged; Obesity; Pancreas; Phenylalanine; Tyrosine; Valine | 1969 |
The effects of test doses of leucine, isoleucine or valine on plasma amino acid levels. The unique effect of leucine.
Topics: Amino Acids; Blood; Fasting; Humans; Isoleucine; Leucine; Male; Obesity; Valine | 1965 |